Eclipsebio Acquires Terrain Bio to Expand Its End-to-End AI Platform for the Design, Manufacturing, and Validation of RNA Therapeutics ...

Eclipsebio has acquired Terrain Bio, a techbio company specializing in AI/ML RNA design and manufacturing analytics.

After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast ...

We knew we had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue. After being described in 2018, this molecule took our team on a six-year journey ...

Cell-cell signaling networks in African turquoise killifish inferred using CellChat from single-nucleus RNA-sequencing data ...

A mysterious RNA molecule found only in breast cancer led researchers on a six-year hunt that uncovered an entire hidden layer of cancer biology. The story began with T3p, a tiny RNA molecule found in ...

Key opportunities lie in next-generation sequencing methods, with hospitals as major end-users and North America as a dominant region RNA Sequencing Service Market RNA Sequencing Service Market Dublin ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

According to research from a team at the University of Utah Health and the University of Nevada, Reno School of Medicine, ...